• M Necati Demir, Uğur Acar, Güngör Sobacı, and Dinçer Göksülük.
• Private Eye Clinic, Ankara, Turkey.
• Turk J Med Sci. 2022 Jun 1; 52 (3): 741746741-746.

BackgroundTo investigate the effect of transcorneal electrical stimulation (TES) therapy in patients with retinitis pigmentosa (RP).MethodsWe performed TES therapy in 21 patients with RP in 12 sessions with 1-week intervals. The following parameters obtained before and after the TES therapy were compared statistically; the best corrected visual acuity (BCVA, logMAR), Ishihara color vision level, multifocal electroretinography (mf-ERG) response, automated visual field (VF) outcome, and the 25-item low vision quality-of-life (LVQOL) questionnaire points.ResultsThe mean age of patients (6 females; 15 males) was 31.67 ± 9.80 years (20-50 years). While increases in BCVA level, color vision level, mf-ERG response in p1 amplitude of ring 1, and LVQOL questionnaire points were statistically significant, changes in VF test and other mf-ERG responses were not. Twenty of the patients (95.24%) stated that they were satisfied with the TES therapy. No considerable side effect was observed in any patient due to the therapy.DiscussionThe TES therapy may be an effective and safe treatment modality in slowing the RP progression, especially in the early stages of the disease. Longer-term follow-ups in larger patient populations are warranted.

14 keywords...

hide…